Brinker Capital Investments’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
KBG
PMG
Brinker Capital Investments's OGN Position: Q1 2026 in Review
Brinker Capital Investments sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 12,790 shares — an estimated $91.7K sold.
Brinker Capital Investments first reported a position in OGN in Q2 2021 and held it in 19 quarters. The position peaked at $2.4M in Q4 2022. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Brinker Capital Investments reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
- Brinker Capital Investments sold 12,790 Organon & Co shares in Q1 2026, an estimated $91.7K.
- Brinker Capital Investments first reported a position in Organon & Co in Q2 2021 and held it in 19 quarters.
- Brinker Capital Investments's Organon & Co position peaked at $2.4M in Q4 2022.
- 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.